Delcath Systems Stock

Delcath Systems Equity

The The Equity of Delcath Systems (DCTH) as of Aug 5, 2026 is 111.22 M USD. In the previous year, The Equity was 68.75 M USD — a change of 61.78% (higher).

Equity

111.22 MUSD

YoY

61.78%

Last updated:

In 2026, Delcath Systems's equity was 111.22 M USD, a 61.78% increase from the 68.75 M USD equity in the previous year.

Access this data via the Eulerpool API

Delcath Systems Stock analysis

What does Delcath Systems do? Delcath Systems Inc is a US-American medical technology company specializing in the development of innovative products for the treatment of various forms of liver cancer. The company was founded in 1988 in New York and is headquartered in Queensbury today. Delcath Systems is one of the most popular companies on Eulerpool.

Equity Details

Analyzing Delcath Systems's Equity

Delcath Systems's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Delcath Systems's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Delcath Systems's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Delcath Systems's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Delcath Systems’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Delcath Systems stock

The Equity of Delcath Systems is 111.22 M USD in 2026.

The Equity of Delcath Systems changed from 68.75 M USD to 111.22 M USD, representing a 61.78% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of The Equity Delcath Systems since 2006 – with annual values, charts, and detailed analysis.

The Equity's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's Delcath Systems historically and in real time.

Access this data via the Eulerpool API

Balance Sheet — Delcath Systems

All Key Metrics — Delcath Systems